By Rebecca Melvin
New York, Feb. 3 – Shanghai Fosun Pharmaceutical (Group) Co., Ltd. issued RMB 1.6 billion of 3.98% four-year bonds on Tuesday.
The company may adjust the coupon rate and the bonds are putable at the end of the second year.
A second five-year tranche putable after three years was canceled, according to the company’s announcement.
This is the company’s first tranche of corporate bonds for 2021. The company previously obtained approval to issue up to RMB 5 billion of corporate bonds.
The pharmaceutical company is a Shanghai-based member of the Hong Kong group Fosun International Ltd.
| Issuer: | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
| Issue: | Corporate bonds, 2021 first tranche
|
| Amount: | RMB 1.6 billion
|
| Maturity: | Four years
|
| Coupon: | 3.98%, may be adjusted at end of second year
|
| Price: | Par of RMB 100
|
| Put option: | At end of second year
|
| Settlement date: | Feb. 2
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
